retatrutide trial results phase 2 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people Retatrutide Results: 28.3% Weight Loss
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



























